Phase II CT-2103/Carboplatin in Ovarian Cancer
Public ClinicalTrials.gov record NCT00069901. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
CT-2103/Carboplatin for Patients With Newly Diagnosed Stage III or IV Ovarian or Primary Peritoneal Cancer: A Phase 2 Study
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate the safety and efficacy of CT-2103 (poly(L)glutamate-paclitaxel) in combination with carboplatin for the treatment of patients with Stage III or IV ovarian or primary peritoneal cancer.
Study identification
- NCT ID
- NCT00069901
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 82 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 2003 (Type not available)
- Primary completion
- Nov 2005 (Actual)
- Completion
- Sep 2006 (Actual)
- Last update posted
- Sep 22, 2008
2003 – 2006
United States locations
- U.S. sites
- 17
- U.S. states
- 12
- U.S. cities
- 15
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| California Cancer Care | Greenbrae | California | 94904 | — |
| Gynecology Oncology Associates | Greenbrae | California | — | — |
| Stockton Hematology Oncology Medical | Stockton | California | 95204 | — |
| Raben and Fldman Research Associates | South Miami | Florida | 33143 | — |
| University of Louisville | Louisville | Kentucky | 40202 | — |
| Resource Center for Gynecology/ Oncology | Kansas City | Missouri | 64132 | — |
| Upstate New York Cancer Research and Education Foundation | Rochester | New York | 98104 | — |
| Gynecology, Oncology, and Pelvic Surgery Associates, Inc. | Columbus | Ohio | 43222 | — |
| Albert Einstein Cancer Center | Philadelphia | Pennsylvania | 19141 | — |
| Guthrie Foundation for Education and Research | Sayre | Pennsylvania | 18840 | — |
| South Carolina Oncology Assoicates | Columbia | South Carolina | 29203 | — |
| Chattanooga GYN-Oncology | Chattanooga | Tennessee | 37403 | — |
| Baptist Regional Cancer Center | Knoxville | Tennessee | 37920 | — |
| Arlington Fairfax Hematology Oncology | Arlington | Virginia | 22205 | — |
| Pacific Gynecology Specialists | Seattle | Washington | 98104 | — |
| Swedish Cancer Institute | Seattle | Washington | 98104 | — |
| Aurora Health Care, Inc. | Milwaukee | Wisconsin | 53201 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00069901, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 22, 2008 · Synced Oct 28, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00069901 live on ClinicalTrials.gov.